Our results demonstrate that ZNF671 promoter methylation is frequently found in urothelial carcinoma and thus, represents a promising, non-invasive biomarker for the detection and guided therapy of urothelial carcinoma. The gene discussed is ZNF671; the disease is urothelial carcinoma.